Nervous system

Global Bone-Anchored Hearing Aids Market to Grow Almost 14% by 2025 - Increasing Prevalence of Hearing Loss - Technavio | Featuring Key Vendors - BHM-Tech Produktionsgesellschaft mbH, Cochlear Ltd., Demant AS, GN Store Nord AS, and Others

Thursday, February 25, 2021 - 3:30pm

In the short term, the market demand will show Superior growth.

Key Points: 
  • In the short term, the market demand will show Superior growth.
  • Bone-anchored hearing aids are used for adults with outer or middle ear malformations, SSD, or hearing loss.
  • These hearing aids are recommended for adults who are unable to use the conventional AC hearing aids or have undergone ossicular replacement surgery because of chronic otitis media.
  • Market growth in this region will be slowerthan the growth of the market in otherregions.

Global Immersive Technology in Healthcare Report 2020: Innovations in Augmented Reality (AR) and Virtual Reality (VR) to Transform the Realm of Surgery, Medical Education, and Therapy

Thursday, February 25, 2021 - 2:45pm

DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "Revolutionizing Future of Care Through Immersive Technologies" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "Revolutionizing Future of Care Through Immersive Technologies" report has been added to ResearchAndMarkets.com's offering.
  • The scope of this GO-TE is global.
  • This GO-TE provides an overview of AR and VR, and the drivers and challenges impacting their adoption.
  • This GO-TE highlights the AR and VR-related innovations in areas such as medical education, surgical planning, surgery guidance and therapies for conditions including mental health and chronic pain.

Signia Showcases Advanced Xperience Hearing Aid & Tinnitus Solutions for Veterans at JDVAC 2021

Wednesday, February 24, 2021 - 2:08pm

PISCATAWAY, N.J., Feb. 24, 2021 /PRNewswire/ --Hearing aid innovator Signia today announced it will showcase its industry-leading Xperience hearing aids and tinnitus solutions at JDVAC 2021 that enable veterans to enhance their human performance through improved hearing in every situation.

Key Points: 
  • PISCATAWAY, N.J., Feb. 24, 2021 /PRNewswire/ --Hearing aid innovator Signia today announced it will showcase its industry-leading Xperience hearing aids and tinnitus solutions at JDVAC 2021 that enable veterans to enhance their human performance through improved hearing in every situation.
  • Throughout the conference, Signia staff will engage with attendees and be available to answer any questions about Signia solutions.
  • In addition to highly innovative hearing aids, Signia also delivers tools and apps to increase customer interaction and engagement at all levels of hearing aid management.
  • Signia, and its hearing care professionals, enable hearing aid wearers to not just correct hearing loss but to gain an edge to Be Brilliant.

Natural Personal Care Leader, J.R. Watkins, Launches Disruptive Topical Pain Relief Remedies Nationwide

Wednesday, February 24, 2021 - 2:00pm

The MUSCLE and COOLING Pain Relief lines provide ingredient-conscious consumers with better-for-you pain relief alternatives without compromising efficacy.

Key Points: 
  • The MUSCLE and COOLING Pain Relief lines provide ingredient-conscious consumers with better-for-you pain relief alternatives without compromising efficacy.
  • J.R. Watkins MUSCLE Pain Relief line offers penetrating pain relief for muscle strains and soreness and aching joints - made with natural Camphor and added Magnesium, Vitamin D, and Peppermint.
  • The COOLING Pain Relief line provides fast-acting pain relief for backaches and joints - made with natural Menthol and added Arnica and Vitamin E. Meet the products:
    The MUSCLE Pain Relief Line-Up:
    MUSCLE Pain Relief Roll-On is small enough for travel and on-the-go, perfect for targeting muscle strains at home or on-the-go ($16.99)
    The COOLING Pain Relief Line-Up:
    COOLING Menthol Extra Strength Pain Relief Roll-On is small enough for travel and on-the-go, perfect for targeting joint pain at home or on-the-go ($15.99)
    The COOLING line launched on JRWatkins.com, January 26, 2021, and today, MUSCLE is now available on the brand website.
  • The MUSCLE Pain Relief line will expand into doors nationwide with CVS Pharmacy starting March 5, 2021.

AppliedVR Completes Pivotal Trial Finding Virtual Reality Is a Holistic Treatment for Chronic Pain

Wednesday, February 24, 2021 - 1:00pm

AppliedVR , a pioneer advancing the next generation of digital medicine, today announced results from its pivotal randomized controlled trial (RCT), evaluating virtual reality (VR) therapy for treating chronic pain at home.

Key Points: 
  • AppliedVR , a pioneer advancing the next generation of digital medicine, today announced results from its pivotal randomized controlled trial (RCT), evaluating virtual reality (VR) therapy for treating chronic pain at home.
  • EaseVRx is an eight-week program delivered via a virtual reality medical device which teaches participants how to recognize and adjust cognitive, emotional, and physical responses to chronic pain using one session per day.
  • Already the most evidence-backed VR provider in healthcare, AppliedVR is engaged with multiple big-name insurers to evaluate its platform as a covered treatment for chronic pain.
  • AppliedVR is a leader in digital therapeutics, pioneering virtual reality-based treatments that address the complexity of chronic pain.

National Spine and Pain Centers Names Douglas Badertscher President

Tuesday, February 23, 2021 - 6:12pm

ROCKVILLE, Md., Feb. 23, 2021 /PRNewswire/ --National Spine and Pain Centers (NSPC), the nation's leading network of interventional pain practices, announced today that Douglas P. Badertscher has joined its leadership team as administrative President.

Key Points: 
  • ROCKVILLE, Md., Feb. 23, 2021 /PRNewswire/ --National Spine and Pain Centers (NSPC), the nation's leading network of interventional pain practices, announced today that Douglas P. Badertscher has joined its leadership team as administrative President.
  • Most recently, Badertscher served as President and COO of Pain Specialists of America.
  • About National Spine and Pain Centers:
    For more than 30 years, NSPC affiliated physicians have been pioneers in the relief of chronic and acute pain through minimally invasive procedures and leading-edge clinical research.
  • Medical services provided by independently operated physician practices branded as National Spine and Pain Centers and other affiliated brands.

Celéri Health Announces Enrollment of First Patient in Study of Real World Outcomes® for Medtronic DTM™ Spinal Cord Stimulation (SCS)

Tuesday, February 23, 2021 - 1:00pm

The clinical study is sponsored by Celri Health and is supported by Medtronics External Research Program.

Key Points: 
  • The clinical study is sponsored by Celri Health and is supported by Medtronics External Research Program.
  • DTM therapy is the first tailored SCS approach intentionally developed from a novel scientific concept and demonstrated in a RCT.
  • DTM SCS therapy is a proprietary spinal cord stimulation algorithm available to treat patients with chronic pain that is delivered as a programming option via the Medtronic Intellis platform.
  • Modulation of neuroglial interactions using differential target multiplexed spinal cord stimulation in an animal model of neuropathic pain.

OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation

Tuesday, February 23, 2021 - 7:00am

10,899,796 entitled Compounds and Methods for Treating Pain was issued by the United States Patent and Trademark Office (USPTO) on January 26, 2021.

Key Points: 
  • 10,899,796 entitled Compounds and Methods for Treating Pain was issued by the United States Patent and Trademark Office (USPTO) on January 26, 2021.
  • This patent covers a class of bovine adrenal medulla (BAM) peptides linked to specific lipids that demonstrate potential for treating symptoms of neuropathic pain, ocular pain, ocular inflammation and/or dry eye disease.
  • These licenses included the rights to the intellectual property (IP) estate covering composition-of-matter and methodology claims on these lipid-linked analogues.
  • OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.

KT Tape Launches KT Recovery+ Wave

Monday, February 22, 2021 - 3:34pm

AMERICAN FORK, Utah, Feb. 22, 2021 /PRNewswire/ -- KT Tape, a leader in drug-free pain relief, today announced the latest innovation in its recovery product line up: KT Recovery+ Wave (KT Wave).

Key Points: 
  • AMERICAN FORK, Utah, Feb. 22, 2021 /PRNewswire/ -- KT Tape, a leader in drug-free pain relief, today announced the latest innovation in its recovery product line up: KT Recovery+ Wave (KT Wave).
  • The new KT Recovery+ Wave uses sensation-free electromagnetic pulses, known clinically as pulsed shortwave therapy (PSWT), to reduce nerve hypersensitivity and relieve pain.
  • Utilizing technology 17 years in the making, KT Wave is a miniaturized, non-prescription product that makes PSWT portable and affordable.
  • For a limited time, enjoy 20% off of your KT Wave purchase from kttape.com/pages/kt-recovery-wave by using the code Wave20.

Healthcare AR and VR Innovations Report 2020: Medical Education, Surgical Planning, Surgery Guidance and Therapies - ResearchAndMarkets.com

Monday, February 22, 2021 - 3:47pm

The "Revolutionizing Future of Care Through Immersive Technologies" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Revolutionizing Future of Care Through Immersive Technologies" report has been added to ResearchAndMarkets.com's offering.
  • The scope of this GO-TE is global.
  • This GO-TE provides an overview of AR and VR, and the drivers and challenges impacting their adoption.
  • This GO-TE highlights the AR and VR-related innovations in areas such as medical education, surgical planning, surgery guidance and therapies for conditions including mental health and chronic pain.